SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583648-18-000049
Filing Date
2018-08-09
Accepted
2018-08-09 16:03:03
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pirs6-30x201810xq.htm 10-Q 666250
2 EXHIBIT 31.1 exhibit311q2.htm EX-31.1 9794
3 EXHIBIT 31.2 exhibit312q2.htm EX-31.2 9613
4 EXHIBIT 32.1 exhibit321q2.htm EX-32.1 5674
5 EXHIBIT 32.2 exhibit322q2.htm EX-32.2 5546
  Complete submission text file 0001583648-18-000049.txt   3237335

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pirs-20180630.xml EX-101.INS 581251
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20180630.xsd EX-101.SCH 28269
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20180630_cal.xml EX-101.CAL 48901
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20180630_def.xml EX-101.DEF 95735
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20180630_lab.xml EX-101.LAB 336734
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20180630_pre.xml EX-101.PRE 188859
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 181004963
SIC: 8731 Services-Commercial Physical & Biological Research